Editorial: can serum triiodothyronine-to-thyroxine (T3/T4) ratio predict safety and efficacy of biologic treatment in IBD?
Aliment Pharmacol Ther
; 53(2): 346-347, 2021 01.
Article
in En
| MEDLINE
| ID: mdl-33368516
Full text:
1
Database:
MEDLINE
Main subject:
Biological Products
/
Inflammatory Bowel Diseases
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Aliment Pharmacol Ther
Year:
2021
Type:
Article
Affiliation country:
United kingdom